A detailed history of Price T Rowe Associates Inc transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 16,103 shares of PAHC stock, worth $349,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,103
Previous 15,924 1.12%
Holding current value
$349,113
Previous $268,000 35.45%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.39 - $22.5 $2,933 - $4,027
179 Added 1.12%
16,103 $363,000
Q2 2024

Aug 14, 2024

BUY
$12.44 - $18.55 $6,605 - $9,850
531 Added 3.45%
15,924 $268,000
Q1 2024

May 15, 2024

BUY
$10.63 - $13.68 $11,299 - $14,541
1,063 Added 7.42%
15,393 $200,000
Q4 2023

Feb 14, 2024

BUY
$9.59 - $12.91 $2,857 - $3,847
298 Added 2.12%
14,330 $166,000
Q3 2023

Nov 14, 2023

BUY
$12.43 - $15.29 $7,010 - $8,623
564 Added 4.19%
14,032 $180,000
Q1 2023

May 15, 2023

BUY
$13.67 - $16.37 $6,889 - $8,250
504 Added 3.89%
13,468 $207,000
Q4 2022

Feb 14, 2023

BUY
$12.05 - $15.14 $1,578 - $1,983
131 Added 1.02%
12,964 $174,000
Q3 2022

Nov 14, 2022

BUY
$12.82 - $20.22 $15,883 - $25,052
1,239 Added 10.69%
12,833 $171,000
Q2 2022

Aug 15, 2022

BUY
$17.89 - $20.47 $3,578 - $4,094
200 Added 1.76%
11,594 $222,000
Q1 2022

May 16, 2022

BUY
$18.39 - $21.85 $6,896 - $8,193
375 Added 3.4%
11,394 $227,000
Q4 2021

Feb 14, 2022

SELL
$18.96 - $22.76 $6,086 - $7,305
-321 Reduced 2.83%
11,019 $225,000
Q2 2021

Aug 16, 2021

BUY
$24.15 - $30.08 $7,897 - $9,836
327 Added 2.97%
11,340 $327,000
Q1 2021

May 17, 2021

SELL
$19.71 - $25.23 $6.39 Million - $8.18 Million
-324,100 Reduced 96.71%
11,013 $269,000
Q4 2020

Feb 16, 2021

BUY
$16.44 - $20.2 $5.51 Million - $6.77 Million
335,113 New
335,113 $6.51 Million

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $441M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.